(MedPage Today) -- The FDA has granted accelerated approval to tarlatamab (Imdelltra) as a second- or later-line option for patients with extensive-stage small cell lung cancer (SCLC) with disease progression on or after platinum-based…
Chemotherapy kills cancer cells, and vitro studies have now uncovered a completely new way in which cancer cells die, linked to the Schlafen 11 (SLFN11) gene, and ribosome stalling. Researchers reporting on the discovery say this route to…
The rate of colorectal cancer screenings more than doubled when patients were given a choice between which type of screening they wanted—a take-home kit or colonoscopy—compared to those who were only offered the colonoscopy, according to…
Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung…
Chemotherapy kills cancer cells. But the way these cells die appears to be different than previously understood. Researchers have now uncovered a completely new way in which cancer cells die: due to the Schlafen11 gene. 'This is a very…
Colorectal cancer differs from patient to patient. That is why scientists are looking for characteristic tumor markers that allow them to make predictions about the likely response to certain therapies and the individual prognosis. The aim…
Finding out that cancer has spread is always unwelcome news. A study from Aarhus University has identified a gene that determines whether patients with prostate cancer develop metastases elsewhere in the body.
Immunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when it's combined with chemotherapy, a new clinical trial reports.
Immunotherapies have revolutionized cancer treatment by harnessing the body's own immune system to attack cancer cells and halt tumor growth. However, these therapies often need to be tailored to each individual patient, slowing down the…
Patients with very advanced solid tumors saw no significant improvement in overall survival after receiving systemic therapy, according to a study published in JAMA Oncology by researchers at The University of Texas MD Anderson Cancer…
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy helps remove the cancer cells more precisely and reduces blood loss, ensuring quicker patient recovery
Health experts at a two-day high level regional seminar on promoting cancer awareness and advocacy programs is seeking innovative approaches for prevention and early detection of cancer. They want better ways of raising awareness to…
Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy -- given before and after surgery -- significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell…
HEPHAISTOS-Pharma, a biotechnology company developing next generation immunotherapies against cancer targeting innate immunity to increase the cure rate of patients, has completed its €4.5 million seed round to finance industrialization…
The Fox News Health Newsletter brings you trending and important stories about health warnings, drug shortages, mental health issues and more in this weekly recap.
Scientists uncover why cancer patients with ARID1A gene mutations are more likely to respond to immunotherapy, discovering ARID1A mutations invite cancer-fighting immune cells into tumors by triggering an antiviral-like response. Their…